Discontinuation of a concomitantly used cytochrome P450 2D6 inhibitor might lead to a lower in codeine plasma concentration and a rise in Lively metabolite morphine plasma focus which could enhance or extend adverse reactions and should lead to perhaps lethal respiratory depression.From Mayo Clinic to the inbox Join no cost and remain up to date on